Coronary artery bypass graft surgery in Brazil from 2008 to 2017

Kalil Hussein Khalil1, Michel Pompeu B O Sá2,3, Dominique Vervoort4

  • 1Department of Cardiovascular Surgery, Hospital Norte Paranaense, Arapongas, Paraná, Brazil.

Insights

Coronary artery bypass grafting (CABG) in Brazil

Area of Science:

  • Cardiovascular Surgery
  • Public Health Systems
  • Health Services Research

Background:

  • Brazil's public health system faces challenges in understanding cardiac surgical care volume and outcomes.
  • Despite advances, data on coronary artery bypass grafting (CABG) in Brazil's public sector is limited.
  • This study addresses the knowledge gap regarding CABG trends and outcomes in Brazil's public healthcare.

Purpose of the Study:

  • To evaluate the outcomes of coronary artery bypass grafting (CABG) procedures within Brazil's public health system.
  • To analyze trends in CABG volume, mortality, and associated factors from 2008 to 2017.
  • To identify regional disparities in CABG outcomes in Brazil's public healthcare.

Main Methods:

  • Utilized DATASUS, the Brazilian Ministry of Health's data processing system, for surgical procedure data.
  • Analyzed isolated coronary artery bypass grafting (CABG) procedures performed between January 2008 and December 2017.
  • Employed statistical analysis, including the chi-squared test, to compare mortality rates across regions and over time.

Main Results:

  • A total of 226,697 coronary artery bypass grafting (CABG) procedures were identified over the 10-year study period.
  • The overall in-hospital mortality rate for CABG was 5.7%, with significant regional variations observed.
  • Mortality rates by state ranged from 2.6% to 13.1%, while the national average remained stable.

Conclusions:

  • A substantial volume of coronary artery bypass grafting (CABG) is performed in Brazil's public health system.
  • Significant disparities exist in CABG mortality, procedure volume, and surgical distribution across Brazilian regions.
  • Future research should focus on risk-adjusted analyses and comprehensive data collection to improve healthcare policies and accountability.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
670
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
5.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
186
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
475